Keele Cardiovascular Research Group, Centre for Prognosis Research, Institute for Primary Care and Health Sciences, Keele University, Newcastle-under-Lyme, UK.
Division of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK.
Diabetologia. 2024 Dec;67(12):2711-2725. doi: 10.1007/s00125-024-06281-7. Epub 2024 Oct 3.
AIMS/HYPOTHESIS: The aim of this study was to investigate how diabetes mellitus affects longer term outcomes in individuals presenting to hospital with non-ST segment elevation myocardial infarction (NSTEMI).
We analysed data from 456,376 adults hospitalised between January 2005 and March 2019 with NSTEMI from the UK Myocardial Ischaemia National Audit Project (MINAP) registry, linked with Office for National Statistics death reporting. We compared outcomes and quality of care by diabetes status.
Individuals with diabetes were older (median age 74 vs 73 years), were more often of Asian ethnicity (13% vs 4%) and underwent revascularisation (percutaneous coronary intervention or coronary artery bypass graft surgery) (38% vs 40%) less frequently than those without diabetes. The mortality risk for those with diabetes compared with those without was significantly higher at 30 days (HR 1.19, 95% CI 1.15, 1.23), 1 year (HR 1.28, 95% CI 1.26, 1.31), 5 years (HR 1.36, 95% CI 1.34, 1.38) and 10 years (HR 1.39, 95% CI 1.36, 1.42). In individuals with diabetes, higher quality inpatient care, assessed by opportunity-based quality indicator (OBQI) score category ('poor', 'fair', 'good' or 'excellent'), was associated with lower mortality rates compared with poor care (good: HR 0.74, 95% CI 0.73, 0.76; excellent: HR 0.69, 95% CI 0.68, 0.71). In addition, compared with poor care, excellent care in the diabetes group was associated with the lowest mortality rates in the diet-treated and insulin-treated subgroups (diet-treated: HR 0.64, 95% CI 0.61, 0.68; insulin-treated: HR 0.69, CI 0.66, 0.72).
CONCLUSION/INTERPRETATION: Individuals with diabetes experience disparities during inpatient care following NSTEMI. They have a higher risk of long-term mortality than those without diabetes, and higher quality inpatient care may lead to better long-term survival.
目的/假设:本研究旨在探讨糖尿病如何影响非 ST 段抬高型心肌梗死(NSTEMI)患者住院期间的长期预后。
我们分析了 2005 年 1 月至 2019 年 3 月期间来自英国心肌梗死国家审计项目(MINAP)登记处的 456376 例患有 NSTEMI 的成年人的数据,这些数据与国家统计局的死亡报告相关联。我们比较了不同糖尿病状态下的结局和护理质量。
与无糖尿病患者相比,糖尿病患者年龄较大(中位数年龄 74 岁 vs 73 岁),亚洲裔(13% vs 4%)更多,接受经皮冠状动脉介入治疗或冠状动脉旁路移植术(38% vs 40%)的频率更低。与无糖尿病患者相比,糖尿病患者的 30 天(HR 1.19,95%CI 1.15,1.23)、1 年(HR 1.28,95%CI 1.26,1.31)、5 年(HR 1.36,95%CI 1.34,1.38)和 10 年(HR 1.39,95%CI 1.36,1.42)死亡率风险显著更高。在糖尿病患者中,以机会性质量指标(OBQI)评分类别(“差”、“中”、“优”或“良”)评估的更高质量的住院护理与死亡率降低相关,与护理较差相比(优:HR 0.74,95%CI 0.73,0.76;良:HR 0.69,95%CI 0.68,0.71)。此外,与护理较差相比,糖尿病组中优级护理与饮食治疗和胰岛素治疗亚组的最低死亡率相关(饮食治疗:HR 0.64,95%CI 0.61,0.68;胰岛素治疗:HR 0.69,CI 0.66,0.72)。
结论/解释:糖尿病患者在 NSTEMI 住院期间存在护理差异。他们的长期死亡率高于无糖尿病患者,更高质量的住院护理可能导致更好的长期生存。